Armephaco JSC

Armephaco JSC FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Armephaco JSC (AMP.VN) as of Oct 18, 2026 is -1,194.21 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 343.09 % — a change of -448.08% (lower).

FCF Conversion

-1,194.21 %

YoY

-448.08%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Armephaco JSC is 2024 -1,194.21 % . FCF Conversion Rate (FCF/EBITDA) of Armephaco JSC was 2023 343.09 % . It decreases by -448.08% lower compared to the previous year.

The Armephaco JSC FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2017
-20.28 VND
Jan 1, 2018
-232.33 VND
Jan 1, 2019
34.31 VND
Jan 1, 2020
-342.78 VND
Jan 1, 2021
1,222.00 VND
Jan 1, 2022
254.36 VND
Jan 1, 2023
343.09 VND
Jan 1, 2024
-1,194.21 VND
The Armephaco JSC FCF Conversion history
YEARFCF ConversionYoY
-1,194.21 %-448.08%
343.09 %+34.88%
254.36 %-79.18%
1,222.00 %-456.50%
-342.78 %-1,099.02%
34.31 %-114.77%
-232.33 %+1,045.73%
-20.28 %-97.57%
-834.40 %+958.07%
-78.86 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Armephaco JSC Stock analysis

What does Armephaco JSC do? Armephaco JSC, listed on the Vietnamese stock market with ticker AMP.VN and ISIN VN000000AMP7, is headquartered in Hanoi, Vietnam. The company went public through an IPO on January 12, 2017. Armephaco engages in the manufacture and distribution of pharmaceutical products and medical equipment. Its product range includes glucose meters, sphygmomanometers, hospital beds, medical examination tables, and syringe destroyers. The company also produces and trades a variety of medicines, such as antibiotics, vitamins, pain relievers, antipyretics, gastrointestinal treatments, and anti-allergic medications. Armephaco operates within the pharmaceutical and medical equipment sector, though specific industry classifications are not detailed. The company's website is http://armephaco.com.vn/. As a publicly traded entity, Armephaco provides healthcare-related products and services to the Vietnamese market, focusing on both medical devices and pharmaceuticals. The company's operations are centered in Hanoi, where it manages its manufacturing and distribution activities. No additional details regarding founding year, key personnel, acquisitions, or financial figures are provided in the available information. Armephaco JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Armephaco JSC stock

FCF Conversion Rate (FCF/EBITDA) of Armephaco JSC is -1,194.21 % in 2024.

FCF Conversion Rate (FCF/EBITDA) of Armephaco JSC changed from 343.09 % to -1,194.21 %, representing a -448.08% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Armephaco JSC since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Armephaco JSC with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Armephaco JSC

All Key Metrics — Armephaco JSC